OIS Podcast Episode #332: Spotlight On Gene & Cell Therapy

WEBSITE

FOLLOW Ophthalmology Innovation Summit On Social Media:

JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn

SUBSCRIBE To Our Weekly OIS Newsletter

VIEW Our Past Ophthalmology Event Conferences:

REGISTER For Our Next Meeting:

#OIS #Ophthalmology #Healthcare

_________________________________________________________________

About OIS

Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.

[annalexander]

My last 2 injection s last week my left eye is blurred can hardly see I get 1 in each eye same day

[Bishop]

Hi. Can anyone with the knowledge please help me find help. I have a very rare eye disease called choroideremia. Because of this life changing disease, I am completely blind in my right eye due to my retina detaching. 😔 What sight I have remaining in my left eye is like looking through a straw. I'm told by my retina specialist that the only hope for me is stem cell therapy. And that trials for that will not begin to take place or at least three to five perhaps even 10 years. Is this true and can anyone please help me before all fields of vision that I have remaining are gone.

[annalexander]

Am getting injection s, once a month 1 in each eye same tome

[MisterDivineAdVenture]

Half expose on the medical myopia and inherent limitations of the professional-society graft, what is presented is a counterpoint to any full-spectrum consideration of health. Everything is about "a drug" to be developed. And the other half about very useful developing techniques for delivering drug and gene therapies and their unique relative benefits and relative safeties. I suspect I will never find a full-spectrum counterpoint in this venue, and the reason why may become apparent. If someone simply "heals" using a full-spectrum approach - there wouldn't be this specialized approach other than for "one and done" verification of the efficacy. The specialty would cavitate. These doctors would have free time on their hands and that would be a disaster for their competitive nature - and economics.

[annalexander]

I don't know how I am how many injections more getting them a year or more my left one after last I feel my I can hardly see